Medgenics Reports Third Quarter 2016 Financial Results
November 03, 2016 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Nov 3, 2016) - Medgenics, Inc. (NASDAQ: MDGN)
Presented Data Confirming Prevalence of Genetic Mutations in Pediatric ADHD at the 63rd...
Medgenics to Host Conference Call to Announce Third Quarter 2016 Financial Results
October 26, 2016 08:30 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Oct 26, 2016) - Medgenics, Inc. (NASDAQ: MDGN) will host a conference call and live audio webcast on Thursday, November 3, 2016 at 8:30 a.m. EST to report financial...
Medgenics, Inc. to Begin Trading on NASDAQ Global Market
October 10, 2016 16:30 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Oct 10, 2016) - Medgenics, Inc. (NYSE MKT: MDGN) (the "Company") announced today that it has been approved for listing on the NASDAQ Global Market, continuing to...
Medgenics to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
September 06, 2016 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Sep 6, 2016) - Medgenics, Inc. (NYSE MKT: MDGN) today announced that Michael F. Cola, President and Chief Executive Officer, will present at the Rodman & Renshaw...
Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial Second Quarter 2016 Results
August 15, 2016 16:15 ET
|
Diffusion Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
Diffusion Pharmaceuticals Appoints Biotech Industry Veteran Isaac Blech to Board of Directors
August 15, 2016 16:10 ET
|
Diffusion Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
Vitae Pharmaceuticals Appoints Scott Applebaum as General Counsel and Corporate Secretary
August 10, 2016 16:05 ET
|
Vitae Pharmaceuticals, Inc.
FORT WASHINGTON, Pa., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE), a clinical-stage biotechnology company, today announced the appointment of Scott Applebaum as...
Medgenics Reports Second Quarter 2016 Financial Results
August 04, 2016 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Aug 4, 2016) - Medgenics, Inc. (NYSE MKT: MDGN)
Initiated Phase 2/3 study of lead program in mGluR+ ADHD
Entered...
Medgenics to Host Conference Call to Announce Second Quarter 2016 Financial Results
July 27, 2016 12:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Jul 27, 2016) - Medgenics, Inc. (NYSE MKT: MDGN) will host a conference call and live audio webcast on Thursday, August 4, 2016 at 8:30 a.m. EDT to report financial...
Medgenics Announces Pricing of Public Offering of Common Stock
June 21, 2016 09:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Jun 21, 2016) - Medgenics, Inc. (NYSE MKT: MDGN) today announced the pricing of 3,640,000 shares of its common stock in a previously announced underwritten...